Showing results (51-60 of 65) with videos related to
Sort By:
Pageof 7
The Oncologist|October 10, 2019
A Phase I Trial Using a Multitargeted Recombinant Adenovirus 5 (CEA/MUC1/Brachyury)-Based Immunotherapy Vaccine Regimen in Patients with Advanced CancerMargaret E Gatti-Mays, Jason M Redman, Renee N Donahue, et al.Cancer Research|October 10, 2024
Stimulating Soluble Guanylyl Cyclase with the Clinical Agonist Riociguat Restrains the Development and Progression of Castration-Resistant Prostate CancerLing Zhang, Clara I Troccoli, Beatriz Mateo-Victoriano, et al.The Oncologist|March 11, 2022
A Randomized Phase II Trial of mFOLFOX6 + Bevacizumab Alone or with AdCEA Vaccine + Avelumab Immunotherapy for Untreated Metastatic Colorectal CancerJason M Redman, Yo-Ting Tsai, Benjamin A Weinberg, et al.The Oncologist|January 14, 2023
A Phase I Single-Arm Study of Biweekly NHS-IL12 in Patients With Metastatic Solid TumorsMargaret E Gatti-Mays, Nicholas P Tschernia, Julius Strauss, et al.Journal for Immunotherapy of Cancer|September 4, 2021
Phase 1 open-label trial of intravenous administration of MVA-BN-brachyury-TRICOM vaccine in patients with advanced cancerPeter J DeMaria, Katherine Lee-Wisdom, Renee N Donahue, et al.Journal for Immunotherapy of Cancer|April 10, 2020
Neoadjuvant PROSTVAC prior to radical prostatectomy enhances T-cell infiltration into the tumor immune microenvironment in men with prostate cancerHoussein Abdul Sater, Jennifer L Marté, Renee N Donahue, et al.The Oncologist|May 3, 2023
Flutamide With or Without PROSTVAC in Non-metastatic Castration Resistant (M0) Prostate CancerRavi A Madan, Marijo Bilusic, Mark N Stein, et al.Journal for Immunotherapy of Cancer|March 5, 2021
Clinical and immunologic impact of short-course enzalutamide alone and with immunotherapy in non-metastatic castration sensitive prostate cancerRavi A Madan, Fatima Karzai, Renee N Donahue, et al.Journal for Immunotherapy of Cancer|December 16, 2020
Bintrafusp alfa, a bifunctional fusion protein targeting TGF-β and PD-L1, in patients with human papillomavirus-associated malignanciesJulius Strauss, Margaret E Gatti-Mays, Byoung Chul Cho, et al.European Urology Oncology|November 14, 2018
Neoadjuvant Dose-dense Gemcitabine and Cisplatin in Muscle-invasive Bladder Cancer: Results of a Phase 2 TrialFern Anari, John O'Neill, Woonyoung Choi, et al.Pageof 7